Clinical Study on the Safety and Initial Efficacy of BGT007 Cell Therapy in Patients With Recurrent/Metastatic Refractory Digestive Tract Tumors
Latest Information Update: 31 Oct 2023
At a glance
- Drugs BGT-007 (Primary)
- Indications Colorectal cancer; Gastric cancer; Oesophageal cancer; Pancreatic cancer
- Focus Adverse reactions
Most Recent Events
- 31 Oct 2023 New trial record